Stock | Dividend Yield | P/E Ratio | Dividend Frequency |
Years Paying |
DGR |
ABBV Abbvie Inc
Challengers
|
4.37% |
23.22
|
4 |
9 |
20%
|
BAYRY BAYER AG
|
0.23% |
8.89
|
1 |
20 |
-26%
|
RHHBY ROCHE HOLDINGS AG
|
0.19% |
27.72
|
1 |
17 |
2%
|
GSK Glaxosmithkline plc
|
5.73% |
21.72
|
3 |
38 |
-1%
|
PFE Pfizer Inc.
Contenders
|
4.31% |
22.68
|
4 |
50 |
6%
|
BMY Bristol-Myers Squibb Co.
Contenders
|
2.99% |
-3005.72
|
4 |
49 |
12%
|
LLY Lilly(Eli) & Co
Challengers
|
1.46% |
33.02
|
4 |
50 |
10%
|
GRFS Grifols SA
|
1.07% |
18.83
|
2 |
8 |
-9%
|
HZNP Horizon Therapeutics Plc
|
- |
24.16
|
- |
- |
-
|
JNJ Johnson & Johnson
Champions
|
2.40% |
25.88
|
4 |
59 |
6%
|
GILD Gilead Sciences, Inc.
Challengers
|
3.91% |
68.02
|
4 |
6 |
9%
|
NVS Novartis AG
|
3.41% |
25.89
|
1 |
24 |
6%
|
AMGN AMGEN Inc.
Contenders
|
2.68% |
19.07
|
4 |
11 |
13%
|
AZN Astrazeneca plc
|
2.80% |
52.61
|
2 |
28 |
-12%
|
BIIB Biogen Inc
|
0.00% |
10.87
|
- |
- |
-
|
GWPH GW Pharmaceuticals
|
0.70% |
-466.17
|
- |
- |
-
|
SNY Sanofi
|
3.52% |
38.82
|
2 |
18 |
2%
|
MRK Merck & Co Inc
Contenders
|
3.24% |
16.73
|
4 |
51 |
8%
|